96 related articles for article (PubMed ID: 1026339)
21. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
22. [Chemotherapy for chronic leukemia].
Kitajima K; Takahashi I; Fujimoto S
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1895-902. PubMed ID: 6964033
[TBL] [Abstract][Full Text] [Related]
23. Evidence for recruitment and synchronization in leukemia and solid tumors.
Mauer AM; Murphy SB; Hayes FA
Cancer Treat Rep; 1976 Dec; 60(12):1841-4. PubMed ID: 1026338
[TBL] [Abstract][Full Text] [Related]
24. Cell kinetics as related to treatment of patients with acute nonlymphoid leukemia.
Lampkin BC
Am J Pediatr Hematol Oncol; 1985; 7(4):358-72. PubMed ID: 2417503
[TBL] [Abstract][Full Text] [Related]
25. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
26. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
[TBL] [Abstract][Full Text] [Related]
27. Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapy.
Burke PJ; Karp JE; Vaughan WP; Sanford PL
Blood Cells; 1982; 8(3):519-33. PubMed ID: 7159763
[TBL] [Abstract][Full Text] [Related]
28. Cell kinetics and chemotherapy: a critical review.
Tannock I
Cancer Treat Rep; 1978 Aug; 62(8):1117-33. PubMed ID: 356975
[TBL] [Abstract][Full Text] [Related]
29. Prediction of the response to chemotherapy in acute leukemia.
Zittoun R; Bouchard M; Facquet-Danis J; Percie-du-Sert M; Bousser J
Cancer; 1975 Feb; 35(2):507-13. PubMed ID: 1111925
[TBL] [Abstract][Full Text] [Related]
30. Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL).
Amadori S; Petti MC; De Francesco A; Chierichini A; Mastrovincenzo C; Testa MG; Mandelli F
Cancer; 1978 Mar; 41(3):1154-60. PubMed ID: 638960
[TBL] [Abstract][Full Text] [Related]
31. The use of cell kinetics in the development of drug combinations.
Valeriote FA
Pharmacol Ther; 1979; 4(1):1-33. PubMed ID: 461499
[No Abstract] [Full Text] [Related]
32. Prediction of the response to chemotherapy in acute leukemia by a short-term test in vitro.
Schwarzmeier JD; Paietta E; Mittermayer K; Pirker R
Cancer; 1984 Feb; 53(3):390-5. PubMed ID: 6692253
[TBL] [Abstract][Full Text] [Related]
33. [Standardized treatment of adult acute leukemia].
Engelhardt R; von d Tann M; Möbius W; Schettler J; Arnold H; Löhr GW
Verh Dtsch Ges Inn Med; 1978; (84):165-8. PubMed ID: 742039
[No Abstract] [Full Text] [Related]
34. Cell kinetics in acute leukemia: a critical reevaluation based on new data.
Hiddemann W; Büchner T; Andreeff M; Wörmann B; Melamed MR; Clarkson BD
Cancer; 1982 Jul; 50(2):250-8. PubMed ID: 7083131
[TBL] [Abstract][Full Text] [Related]
35. [Pharmakokinetics of hydroxy-urea. Therapy of acute myeoblastic leukemias using synchronization and recruitment effects (author' transl)].
Sauer H; Pelka R; Wilmanns W
Klin Wochenschr; 1976 Mar; 54(5):203-9. PubMed ID: 1062636
[TBL] [Abstract][Full Text] [Related]
36. Prediction of responses to therapy and mechanisms of resistance.
Hall TC
Semin Oncol; 1977 Jun; 4(2):193-202. PubMed ID: 327553
[No Abstract] [Full Text] [Related]
37. Proliferation kinetics and cyclic AMP as prognostic factors in adult acute leukemia.
Paietta E; Mittermayer K; Schwarzmeier J
Cancer; 1980 Jul; 46(1):102-8. PubMed ID: 6248186
[TBL] [Abstract][Full Text] [Related]
38. In vivo perturbation of human marrow cell cycle progression by ifosfamide.
Rentschler RE; Barlogie B; Johnston DA; Bodey GP
Cancer Res; 1978 Aug; 38(8):2209-15. PubMed ID: 667817
[No Abstract] [Full Text] [Related]
39. [A preliminary report of a quick method for determining drug sensitivity of leukemic cells in vitro (author's transl)].
Da WM
Zhonghua Nei Ke Za Zhi; 1982 Feb; 21(2):109-12. PubMed ID: 7094702
[No Abstract] [Full Text] [Related]
40. Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry.
Neubauer A; Sauer H; Valet G
Blut; 1987 Nov; 55(5):433-45. PubMed ID: 3676521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
